Invesaro

Stocks Comparison

Trulieve Cannabis vs Usana Health Sciences: revenue, profit, margins and growth compared

Trulieve Cannabis brought in $1.2B of revenue in fiscal 2025, Usana Health Sciences $925.3M in fiscal 2025. Revenue changed by -0.4% at Trulieve Cannabis and +8.3% at Usana Health Sciences on the year before, so Usana Health Sciences grew faster. Trulieve Cannabis kept -9.9% of its revenue as net profit, Usana Health Sciences 1.2%. Free cash flow was $228.6M at Trulieve Cannabis and $8.5M at Usana Health Sciences.

Side by side, latest fiscal year

TRLVUSNA
Fiscal year endedFY2025 (December 31, 2025)FY2025 (January 3, 2026)
Revenue$1.2B$925.3M
Revenue growth-0.4%+8.3%
Net income-$116.4M$10.8M
Net margin-9.9%1.2%
Free cash flow$228.6M$8.5M
Free cash flow margin19.4%0.9%
Earnings per share (diluted)-$0.58$0.58
Cash$255.5M$158.4M
Debt$136.7Mn/a
Price to earningsn/a25.0
Market value$2.4B$267.9M
Dividend yieldn/an/a
Rank by revenue in sector#137 of 523 · Health care#150 of 523 · Health care

Over the years

Revenue
TRLV FY2019: $252.8MTRLV FY2021: $521.5MTRLV FY2021: $931.9MTRLV FY2022: $1.2BTRLV FY2023: $1.1BTRLV FY2024: $1.2BTRLV FY2025: $1.2BUSNA FY2018: $1.2BUSNA FY2019: $1.1BUSNA FY2020: $1.1BUSNA FY2022: $1.2BUSNA FY2022: $998.6MUSNA FY2023: $921MUSNA FY2023: $854.5MUSNA FY2025: $925.3MFY18FY19FY20FY21FY22FY23FY24FY25
TRLV $1.2BUSNA $925.3M
Net income
TRLV FY2019: $53.1MTRLV FY2021: $63MTRLV FY2021: $17.4MTRLV FY2022: -$252.7MTRLV FY2023: -$526.8MTRLV FY2024: -$155.1MTRLV FY2025: -$116.4MUSNA FY2018: $126.2MUSNA FY2019: $100.5MUSNA FY2020: $124.7MUSNA FY2022: $116.5MUSNA FY2022: $69.4MUSNA FY2023: $63.8MUSNA FY2023: $42MUSNA FY2025: $10.8MFY18FY19FY20FY21FY22FY23FY24FY25
TRLV -$116.4MUSNA $10.8M
Net margin
TRLV FY2019: 21.0%TRLV FY2021: 12.1%TRLV FY2021: 1.9%TRLV FY2022: -20.7%TRLV FY2023: -46.7%TRLV FY2024: -13.1%TRLV FY2025: -9.9%USNA FY2018: 10.6%USNA FY2019: 9.5%USNA FY2020: 11.0%USNA FY2022: 9.8%USNA FY2022: 6.9%USNA FY2023: 6.9%USNA FY2023: 4.9%USNA FY2025: 1.2%FY18FY19FY20FY21FY22FY23FY24FY25
TRLV -9.9%USNA 1.2%
Revenue growth
TRLV FY2021: +106.3%TRLV FY2021: +78.7%TRLV FY2022: +30.7%TRLV FY2023: -7.3%TRLV FY2024: +5.1%TRLV FY2025: -0.4%USNA FY2019: -10.8%USNA FY2020: +7.0%USNA FY2022: +4.6%USNA FY2022: -15.8%USNA FY2023: -7.8%USNA FY2023: -7.2%USNA FY2025: +8.3%FY19FY20FY21FY22FY23FY24FY25
TRLV -0.4%USNA +8.3%
Free cash flow
TRLV FY2019: -$52.8MTRLV FY2021: -$298KTRLV FY2021: -$263MTRLV FY2022: -$141.7MTRLV FY2023: $161.6MTRLV FY2024: $148.9MTRLV FY2025: $228.6MUSNA FY2018: $140.7MUSNA FY2019: $110.2MUSNA FY2020: $145.3MUSNA FY2022: $108.5MUSNA FY2022: $93.5MUSNA FY2023: $56.1MUSNA FY2023: $50.9MUSNA FY2025: $8.5MFY18FY19FY20FY21FY22FY23FY24FY25
TRLV $228.6MUSNA $8.5M

Fiscal years as each company reports them; the two may end in different months.

Questions about Trulieve Cannabis and Usana Health Sciences

Which is bigger by revenue, Trulieve Cannabis or Usana Health Sciences?

Trulieve Cannabis is bigger by revenue: $1.2B in fiscal 2025, against $925.3M for Usana Health Sciences in fiscal 2025.

Which keeps more of its revenue as profit, Trulieve Cannabis or Usana Health Sciences?

Trulieve Cannabis had a net margin of -9.9% in fiscal 2025; Usana Health Sciences had 1.2% in fiscal 2025.

Which grew revenue faster, Trulieve Cannabis or Usana Health Sciences?

In their latest fiscal years revenue changed by -0.4% at Trulieve Cannabis and +8.3% at Usana Health Sciences.

Where do these numbers come from?

From the annual reports each company files with the SEC (10-K, or 20-F and 40-F for foreign companies), read from their XBRL data. Margins and growth are simple arithmetic on those figures. Nothing here is a recommendation.

More comparisons

Compare more companies